Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 Quarterly Earnings

Forest sees quarterly and annual sales sink

April 23, 2013

Generic Lexapro sapped company sales for the fiscal quarter and year, ended March 31.
 

Oncology lifts Roche's Q1, Lucentis finds new fans

April 11, 2013

Roche's oncology trifecta of Herceptin, Avastin and mabThera/Rituxan buoyed quarterly sales. Devices and diagnostics sales were solid, if less impressive.
 

Company news: BMS goes over the patent cliff

October 24, 2012

Sales of Bristol-Myers Squibb's Plavix plunged 96% in the third quarter over the same period last year, contributing mightily to an overall 30% drop in sales of the company's products for the quarter, to $3.7 billion.
 

Amgen's Prolia, Enbrel get sales overhauls, DTC

October 24, 2012

Sales of Amgen's Prolia are set to rise after a "soft" quarter, thanks to a sales force overhaul and an impending return to TV advertising, the company said in a third quarter results call.
 

Lilly sales dip 11% as diabetes drugs feel payer pressure

October 24, 2012

Price increases and belt-tightening helped prop up Eli Lilly's third quarter, but loss of formulary positioning on two key products hurt sales.
 

J&J, Roche reports lifted by strong drug sales

October 16, 2012

J&J and Roche reported modest sales increases, with pharma sales providing a boost for J&J and oncology driving Roche's nine- month performance.
 

Biogen Idec sees revenue surge on MS drug sales

July 24, 2012

Biogen Idec saw revenue rise 18% in the second quarter to $1.4 billion amid strong sales of Avonex, with a host of promising late-stage pipeline products waiting in the wings.
 

Abbott, on track for split, posts strong Q2 numbers

July 18, 2012

Abbott Labs reported strong second quarter sales that, though mitigated by an unfavorable exchange rate, cheered analysts and investors, with muscular growth in Humira sales a high point.
 

J&J reports sales slip as Weldon exits

April 17, 2012

Johnson & Johnson reported a 0.2% drop in overall sales for the first quarter of 2012, compared with the same period the year before, as CEO Bill Weldon prepared to hand over the reins of the company.
 
  

Web Exclusive

Angelina Jolie's fearless but flawed message

Paul Oestreicher, Ph.D. May 17, 2013

Angelina Jolie's story raises important questions about education, outreach and access—but her nod to holistic treatments is less helpful
 

Podcasts

How to engage even the busiest physicians

March 04, 2013

Sponsored by TRUE Health + Wellness. The increasingly demanding schedules of healthcare professionals continue to narrow the window of opportunity for pharma sales teams, and, as a result, marketers are focusing more on non-personal promotion. However, there's a lot more to it than simply bombarding physicians with brand messages, as Anne Stroup, Managing Director at TRUE Health + Wellness, explains to MM&M's James Chase in this special podcast presentation.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Acquisition Adherence Advertising Allergy Anaphylaxis Anti-infective App Approval Centers For Disease Control COPD Diabetes DTC Elan FDA Generic Generic Drugs Lymphoma Marketing & Communications Mobile Oncology Patient Advocacy Pipeline Regulatory Research & Development Roche